Emerging bunion therapies, including Magnezix CS and Lapiplasty 3-Dimensional Bunion Correction, are poised to boost market growth by providing innovative, minimally invasive solutions that enhance patient outcomes and accelerate recovery. Along with rising awareness, increasing prevalence—particularly among women, and growing demand for effective surgical and non-surgical options, these advancements are expected to drive the bunion market forward in the coming years.
DelveInsight has launched a new report on "Bunion - Market Insights, Epidemiology, and Market Forecast-2034” that delivers an in-depth understanding of the Bunion, historical and forecasted epidemiology as well as the bunion market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Request for a detailed bunion market sample report @ https://www.delveinsight.com/report-store/bunion-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr
Some of the key facts of the Bunion Market Report:
-
According to DelveInsight, there were approximately 190 million prevalent cases of hallux valgus in the 7MM in 2023, with the United States accounting for the largest share of the bunion treatment market. In the US alone, there were about 100 million mild cases, 40 million moderate cases, and 10 million severe cases, with females 2–3 times more likely than males to be affected.
-
The current bunion treatment pipeline is limited, with most emerging therapies, such as PRF-110 and CPL-01, primarily focusing on symptom relief rather than addressing the underlying deformity.
-
In regulatory developments, DePuy Synthes (Johnson & Johnson) received FDA 510(k) clearance for its TriLEAP™ Lower Extremity Anatomic Plating System, a modular platform designed for foot and ankle procedures, including bunionectomies, expected to launch in the US in 2024. Additionally, in August 2024, PainReform reported progress in identifying the optimal delivery method for PRF-110 in bunionectomy procedures, positioning it as a promising option for post-surgical pain management.
-
Key companies advancing the bunion treatment landscape include Syntellix, Treace Medical Concepts, Wright Medical Technology, Trilliant Surgical, Arthrosurface, Nextremity Solutions, among others. Prominent pipeline candidates under development include CPL-01, PRF-110, and additional therapies aimed at improving outcomes for bunion patients.
Key benefits of the Bunion market report:
-
The bunion market report covers a descriptive overview and comprehensive insights into the Bunion Epidemiology and market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan).
-
The Bunion market report provides insights into the current and emerging therapies.
-
The Bunion market report provides a global historical and forecasted market covering drug outreach in 7MM.
-
The Bunion market report offers an edge that helps in developing business strategies by understanding the trends shaping and driving the Bunion market.
Got queries? Click here to know more about the bunion market landscape https://www.delveinsight.com/sample-request/bunion-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr
Bunion Overview
Hallux valgus, commonly known as a bunion, is a prevalent foot deformity in which the big toe deviates outward at the first metatarsophalangeal joint, creating a prominent bony bump along the inner side of the foot. The condition arises from a combination of genetic factors, anatomical variations, and environmental influences, such as wearing tight or high-heeled shoes, which can exacerbate the deformity. The lateral displacement of the first metatarsal and rotation of the big toe often leads to pain during walking or weight-bearing activities.
Diagnosis is primarily clinical, based on a thorough physical examination and patient history. Common symptoms include pain, swelling, and redness over the bunion, often worsened by constrictive footwear. Clinicians evaluate toe alignment and associated complications like calluses or bursitis. X-rays are used to confirm the diagnosis and determine deformity severity by measuring the hallux valgus angle (HVA) and intermetatarsal angle (IMA). An HVA greater than 15° indicates hallux valgus, with severity classified as mild, moderate, or severe.
Bunion Market Outlook
Leading companies in the bunion treatment sector—such as Concentric Analgesics, Pacira Pharmaceuticals, Cali Pharmaceuticals, and PainReform—are actively progressing their key drug candidates through various stages of clinical development, aiming to evaluate their potential for managing bunions.
In 2023, conservative management accounted for roughly 40% of the 7MM bunion market revenue, while bunionectomy remained the dominant approach, capturing about 60%. Among the EU4 and the UK, Germany led in revenue with approximately USD 700 million, and France contributed around 20% of the market share within that region.
Explore how the bunion market is rising in the upcoming years @ https://www.delveinsight.com/report-store/bunion-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr
Bunion Marketed Drugs
-
Magnezix CS: Syntellix
-
Lapiplasty 3-Dimensional Bunion Correction: Treace Medical Concepts
-
PROstep Minimally Invasive Surgery System: Stryker
Bunion Emerging Drugs
-
CPL-01: Cali Pharmaceuticals
-
PRF-110: PainReform
To know more about the therapies that are driving the Bunion treatment market, visit: https://www.delveinsight.com/sample-request/bunion-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr
Scope of the Bunion Market Report
-
Study Period: 2020-2034
-
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
-
Key Bunion Companies: Syntellix, Treace Medical Concepts, Wright Medical Technology, Trilliant Surgical, Arthrosurface, Nextremity Solutions, Wright medical, and others
-
Key Bunion Therapies: CPL-01, PRF-110, and others.
-
Bunion Therapeutic Assessment: Bunion current marketed and bunion emerging therapies
-
Bunion Market Dynamics: Bunion market drivers and bunion market barriers
-
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
-
Bunion Unmet Needs, KOL's views, Analyst's views, Bunion Market Access and Reimbursement
Table of Contents
1. Report Introduction
2. Executive Summary
3. SWOT analysis
4. Bunion Patient Share (%) Overview at a Glance
5. Bunion Market Overview at a Glance
6. Bunion Disease Background and Overview
7. Bunion Epidemiology and Patient Population
8. Country-Specific Patient Population of Bunion
9. Bunion Current Treatment and Medical Practices
10. Unmet Needs
11. Bunion Emerging Therapies
12. Bunion Market Outlook
13. Country-Wise Bunion Market Analysis (2020–2034)
14. Market Access and Reimbursement of Therapies
15. Market drivers
16. Market barriers
17. Appendix
18. Bunion Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Click here to read more about bunion Market Outlook 2034 @ https://www.delveinsight.com/report-store/bunion-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr
Related Reports:
Bunion Pipeline Insights, DelveInsight
"Bunion Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Bunion market. A detailed picture of the Bunion pipeline landscape is provided, including a disease overview and treatment guidelines for Bunion.
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email:Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/
